Abstract
Alzheimer's disease (AD) is characterized by a wide loss of synapses and dendritic spines. Despite extensive efforts, the molecular mechanisms driving this detrimental alteration have not yet been determined. Among the factors potentially mediating this loss of neuronal connectivity, the contribution of Rho GTPases is of particular interest. This family of proteins is classically considered a key regulator of actin cytoskeleton remodeling and dendritic spine maintenance, but new insights into the complex dynamics of its regulation have recently determined how its signaling cascade is still largely unknown, both in physiological and pathological conditions. Here, we review the growing evidence supporting the potential involvement of Rho GTPases in spine loss, which is a unanimously recognized hallmark of early AD pathogenesis. We also discuss some new insights into Rho GTPase signaling framework that might explain several controversial results that have been published. The study of the connection between AD and Rho GTPases represents a quite unchartered avenue that holds therapeutic potential.
Similar content being viewed by others
References
Hardy J (2009) The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem 110(4):1129–1134. doi:10.1111/j.1471-4159.2009.06181.x
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580):353–356. doi:10.1126/science.1072994
Krafft GA, Klein WL (2010) ADDLs and the signaling web that leads to Alzheimer's disease. Neuropharmacology 59(4–5):230–242. doi:10.1016/j.neuropharm.2010.07.012
Chabrier MA, Blurton-Jones M, Agazaryan AA, Nerhus JL, Martinez-Coria H, LaFerla FM (2012) Soluble Abeta promotes wild-type tau pathology in vivo. J Neurosci 32(48):17345–17350. doi:10.1523/JNEUROSCI.0172-12.2012
Cavallucci V, D'Amelio M, Cecconi F (2012) Abeta toxicity in Alzheimer's disease. Mol Neurobiol 45(2):366–378. doi:10.1007/s12035-012-8251-3
Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM (2012) Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 15(9):1227–1235. doi:10.1038/nn.3178 nn.3178
Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27(4):796–807. doi:10.1523/JNEUROSCI.3501-06.2007
Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457(7233):1128–1132. doi:10.1038/nature07761
Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362(4):329–344. doi:10.1056/NEJMra0909142 362/4/329
Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kovari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG (2012) Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 71(5):362–381. doi:10.1097/NEN.0b013e31825018f7
Castellani RJ, Lee HG, Siedlak SL, Nunomura A, Hayashi T, Nakamura M, Zhu X, Perry G, Smith MA (2009) Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta. J Alzheimers Dis 18(2):447–452. doi:10.3233/JAD-2009-1151 GP32KR1683114225
Lee HG, Zhu X, Castellani RJ, Nunomura A, Perry G, Smith MA (2007) Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses. J Pharmacol Exp Ther 321(3):823–829. doi:10.1124/jpet.106.114009
Bettens K, Sleegers K, Van Broeckhoven C (2010) Current status on Alzheimer disease molecular genetics: from past, to present, to future. Hum Mol Genet 19(R1):R4–R11. doi:10.1093/hmg/ddq142
Heilig EA, Xia W, Shen J, Kelleher RJ 3rd (2010) A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity. J Biol Chem 285(29):22350–22359. doi:10.1074/jbc.M110.116962
Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R (2003) APP processing and synaptic function. Neuron 37(6):925–937
Puzzo D, Privitera L, Leznik E, Fa M, Staniszewski A, Palmeri A, Arancio O (2008) Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28(53):14537–14545. doi:10.1523/JNEUROSCI.2692-08.2008
Puzzo D, Arancio O (2013) Amyloid-beta peptide: Dr. Jekyll or Mr Hyde? J Alzheimers Dis 33(Suppl 1):S111–S120. doi:10.3233/JAD-2012-129033
Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66(12):1837–1844. doi:10.1212/01.wnl.0000219668.47116.e6
Perl DP (2010) Neuropathology of Alzheimer's disease. Mt Sinai J Med N Y 77(1):32–42. doi:10.1002/msj.20157
Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ (2007) Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68(18):1501–1508. doi:10.1212/01.wnl.0000260698.46517.8f
Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30(4):572–580. doi:10.1002/ana.410300410
Palop JJ, Chin J, Mucke L (2006) A network dysfunction perspective on neurodegenerative diseases. Nature 443(7113):768–773. doi:10.1038/nature05289
Penzes P, Vanleeuwen JE (2011) Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease. Brain Res Rev 67(1–2):184–192. doi:10.1016/j.brainresrev.2011.01.003
Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44(1):181–193. doi:10.1016/j.neuron.2004.09.010
Coleman PD, Yao PJ (2003) Synaptic slaughter in Alzheimer's disease. Neurobiol Aging 24(8):1023–1027
Scheff SW, Price DA (1993) Synapse loss in the temporal lobe in Alzheimer's disease. Ann Neurol 33(2):190–199. doi:10.1002/ana.410330209
Arendt T (2009) Synaptic degeneration in Alzheimer's disease. Acta Neuropathol 118(1):167–179. doi:10.1007/s00401-009-0536-x
Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW Jr, Morris JC (2001) Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 56(1):127–129
Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL (2004) Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 24(45):10191–10200. doi:10.1523/JNEUROSCI.3432-04.2004
Koffie RM, Hashimoto T, Tai HC, Kay KR, Serrano-Pozo A, Joyner D, Hou S, Kopeikina KJ, Frosch MP, Lee VM, Holtzman DM, Hyman BT, Spires-Jones TL (2012) Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-beta. Brain 135(Pt 7):2155–2168. doi:10.1093/brain/aws127
Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27(11):2866–2875. doi:10.1523/JNEUROSCI.4970-06.2007
Cullen WK, Suh YH, Anwyl R, Rowan MJ (1997) Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. NeuroReport 8(15):3213–3217
Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95(11):6448–6453
Itoh A, Akaike T, Sokabe M, Nitta A, Iida R, Olariu A, Yamada K, Nabeshima T (1999) Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats. Eur J Pharmacol 382(3):167–175
Chen QS, Kagan BL, Hirakura Y, Xie CW (2000) Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J Neurosci Res 60(1):65–72
Freir DB, Holscher C, Herron CE (2001) Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J Neurophysiol 85(2):708–713
Kim JH, Anwyl R, Suh YH, Djamgoz MB, Rowan MJ (2001) Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J Neurosci 21(4):1327–1333
Malm T, Ort M, Tahtivaara L, Jukarainen N, Goldsteins G, Puolivali J, Nurmi A, Pussinen R, Ahtoniemi T, Miettinen TK, Kanninen K, Leskinen S, Vartiainen N, Yrjanheikki J, Laatikainen R, Harris-White ME, Koistinaho M, Frautschy SA, Bures J, Koistinaho J (2006) beta-Amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or beta-amyloid deposits. Proc Natl Acad Sci U S A 103(23):8852–8857. doi:10.1073/pnas.0602896103
Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M (2002) Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci U S A 99(20):13217–13221. doi:10.1073/pnas.172504199
Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ (2002) Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans 30(4):552–557. doi:http://www.ncbi.nlm.nih.gov/pubmed/12196135
Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416(6880):535–539. doi:10.1038/416535a
Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14(8):837–842. doi:10.1038/nm1782
Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D (2009) Soluble oligomers of amyloid Beta protein facilitate hippocampal long–term depression by disrupting neuronal glutamate uptake. Neuron 62(6):788–801. doi:10.1016/j.neuron.2009.05.012
Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R (2006) AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52(5):831–843. doi:10.1016/j.neuron.2006.10.035
Marcello E, Epis R, Saraceno C, Di Luca M (2012) Synaptic dysfunction in Alzheimer's disease. Adv Exp Med Biol 970:573–601. doi:10.1007/978-3-7091-0932-8_25
Crimins JL, Rocher AB, Luebke JI (2012) Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy. Acta Neuropathol 124(6):777–795. doi:10.1007/s00401-012-1038-9
Crimins JL, Rocher AB, Peters A, Shultz P, Lewis J, Luebke JI (2011) Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy. Acta Neuropathol 122(5):551–564. doi:10.1007/s00401-011-0877-0
Zempel H, Mandelkow EM (2012) Linking amyloid-beta and tau: amyloid-beta induced synaptic dysfunction via local wreckage of the neuronal cytoskeleton. Neurodegener Dis 10(1–4):64–72. doi:10.1159/000332816
Palop JJ, Mucke L (2010) Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci 13(7):812–818. doi:10.1038/nn.2583
Crimins JL, Pooler A, Polydoro M, Luebke JI, Spires-Jones TL (2013) The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease. Ageing Res Rev 12(3):757–763. doi:10.1016/j.arr.2013.03.002
Tampellini D, Gouras GK (2010) Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease. Front Aging Neurosci 2. doi:10.3389/fnagi.2010.00013
Spires-Jones T, Knafo S (2012) Spines, plasticity, and cognition in Alzheimer's model mice. Neural Plast 2012:319836. doi:10.1155/2012/319836
Bhatt DH, Zhang S, Gan WB (2009) Dendritic spine dynamics. Annu Rev Physiol 71:261–282. doi:10.1146/annurev.physiol.010908.163140
Zhou Q, Homma KJ, Poo MM (2004) Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses. Neuron 44(5):749–757. doi:10.1016/j.neuron.2004.11.011
Yang Y, Zhou Q (2009) Spine modifications associated with long-term potentiation. Neuroscientist 15(5):464–476. doi:10.1177/1073858409340800
Penzes P, Cahill ME, Jones KA, VanLeeuwen JE, Woolfrey KM (2011) Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 14(3):285–293. doi:10.1038/nn.2741
Hotulainen P, Hoogenraad CC (2010) Actin in dendritic spines: connecting dynamics to function. J Cell Biol 189(4):619–629. doi:10.1083/jcb.201003008
Penzes P, Rafalovich I (2012) Regulation of the actin cytoskeleton in dendritic spines. Adv Exp Med Biol 970:81–95. doi:10.1007/978-3-7091-0932-8_4
Matus A (2005) Growth of dendritic spines: a continuing story. Curr Opin Neurobiol 15(1):67–72. doi:10.1016/j.conb.2005.01.015
Cerri C, Fabbri A, Vannini E, Spolidoro M, Costa M, Maffei L, Fiorentini C, Caleo M (2011) Activation of rho GTPases triggers structural remodeling and functional plasticity in the adult rat visual cortex. J Neurosci 31(42):15163–15172. doi:10.1523/JNEUROSCI.2617-11.2011
Bongmba OY, Martinez LA, Elhardt ME, Butler K, Tejada-Simon MV (2011) Modulation of dendritic spines and synaptic function by Rac1: a possible link to fragile X syndrome pathology. Brain Res 1399:79–95. doi:10.1016/j.brainres.2011.05.020
Hall A, Lalli G (2010) Rho and Ras GTPases in axon growth, guidance, and branching. Cold Harb Perspect Biol 2(2):a001818. doi:10.1101/cshperspect.a001818
Martino A, Ettorre M, Musilli M, Lorenzetto E, Buffelli M, Diana G (2013) Rho GTPase-dependent plasticity of dendritic spines in the adult brain. Front Cell Neurosci 7:62. doi:10.3389/fncel.2013.00062
Tolias KF, Duman JG, Um K (2011) Control of synapse development and plasticity by Rho GTPase regulatory proteins. Prog Neurobiol 94(2):133–148. doi:10.1016/j.pneurobio.2011.04.011
Chen C, Wirth A, Ponimaskin E (2012) Cdc42: an important regulator of neuronal morphology. Int J Biochem Cell Biol 44(3):447–451. doi:10.1016/j.biocel.2011.11.022
Sekino Y, Kojima N, Shirao T (2007) Role of actin cytoskeleton in dendritic spine morphogenesis. Neurochem Int 51(2–4):92–104. doi:10.1016/j.neuint.2007.04.029
Miller MB, Yan Y, Eipper BA, Mains RE (2013) Neuronal Rho GEFs in synaptic physiology and behavior. Neuroscientist 19(3):255–273. doi:10.1177/1073858413475486
Machacek M, Hodgson L, Welch C, Elliott H, Pertz O, Nalbant P, Abell A, Johnson GL, Hahn KM, Danuser G (2009) Coordination of Rho GTPase activities during cell protrusion. Nature 461(7260):99–103. doi:10.1038/nature08242
Niederost B, Oertle T, Fritsche J, McKinney RA, Bandtlow CE (2002) Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci 22(23):10368–10376
Zhang H, Macara IG (2006) The polarity protein PAR-3 and TIAM1 cooperate in dendritic spine morphogenesis. Nat Cell Biol 8(3):227–237. doi:10.1038/ncb1368
Zhang H, Macara IG (2008) The PAR-6 polarity protein regulates dendritic spine morphogenesis through p190 RhoGAP and the Rho GTPase. Dev Cell 14(2):216–226. doi:10.1016/j.devcel.2007.11.020
Muly EC, Nairn AC, Greengard P, Rainnie DG (2008) Subcellular distribution of the Rho-GEF Lfc in primate prefrontal cortex: effect of neuronal activation. J Comp Neurol 508(6):927–939. doi:10.1002/cne.21703
Edwards DC, Sanders LC, Bokoch GM, Gill GN (1999) Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol 1(5):253–259. doi:10.1038/12963
Arber S, Han B, Mendelsohn M, Smith M, Jessell TM, Sockanathan S (1999) Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron 23(4):659–674
Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K, Nishida E, Mizuno K (1998) Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 393(6687):809–812. doi:10.1038/31735
Tomasevic N, Jia Z, Russell A, Fujii T, Hartman JJ, Clancy S, Wang M, Beraud C, Wood KW, Sakowicz R (2007) Differential regulation of WASP and N-WASP by Cdc42, Rac1, Nck, and PI(4,5)P2. Biochemistry 46(11):3494–3502. doi:10.1021/bi062152y
Wegner AM, Nebhan CA, Hu L, Majumdar D, Meier KM, Weaver AM, Webb DJ (2008) N-wasp and the arp2/3 complex are critical regulators of actin in the development of dendritic spines and synapses. J Biol Chem 283(23):15912–15920. doi:10.1074/jbc.M801555200
Miki H, Suetsugu S, Takenawa T (1998) WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac. EMBO J 17(23):6932–6941. doi:10.1093/emboj/17.23.6932
Soderling SH, Guire ES, Kaech S, White J, Zhang F, Schutz K, Langeberg LK, Banker G, Raber J, Scott JD (2007) A WAVE-1 and WRP signaling complex regulates spine density, synaptic plasticity, and memory. J Neurosci 27(2):355–365. doi:10.1523/JNEUROSCI.3209-06.2006
Kim Y, Sung JY, Ceglia I, Lee KW, Ahn JH, Halford JM, Kim AM, Kwak SP, Park JB, Ho Ryu S, Schenck A, Bardoni B, Scott JD, Nairn AC, Greengard P (2006) Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology. Nature 442(7104):814–817. doi:10.1038/nature04976
Korobova F, Svitkina T (2010) Molecular architecture of synaptic actin cytoskeleton in hippocampal neurons reveals a mechanism of dendritic spine morphogenesis. Mol Biol Cell 21(1):165–176. doi:10.1091/mbc.E09-07-0596
Hotulainen P, Llano O, Smirnov S, Tanhuanpaa K, Faix J, Rivera C, Lappalainen P (2009) Defining mechanisms of actin polymerization and depolymerization during dendritic spine morphogenesis. J Cell Biol 185(2):323–339. doi:10.1083/jcb.200809046
Tashiro A, Minden A, Yuste R (2000) Regulation of dendritic spine morphology by the rho family of small GTPases: antagonistic roles of Rac and Rho. Cereb Cortex 10(10):927–938
Schubert V, Dotti CG (2007) Transmitting on actin: synaptic control of dendritic architecture. J Cell Sci 120(Pt 2):205–212. doi:10.1242/jcs.03337
Murakoshi H, Wang H, Yasuda R (2011) Local, persistent activation of Rho GTPases during plasticity of single dendritic spines. Nature 472(7341):100–104. doi:10.1038/nature09823 nature09823
Asrar S, Meng Y, Zhou Z, Todorovski Z, Huang WW, Jia Z (2009) Regulation of hippocampal long-term potentiation by p21-activated protein kinase 1 (PAK1). Neuropharmacology 56(1):73–80. doi:10.1016/j.neuropharm.2008.06.055
Rex CS, Chen LY, Sharma A, Liu J, Babayan AH, Gall CM, Lynch G (2009) Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation. J Cell Biol 186(1):85–97. doi:10.1083/jcb.200901084 jcb.200901084
O'Kane EM, Stone TW, Morris BJ (2003) Distribution of Rho family GTPases in the adult rat hippocampus and cerebellum. Brain Res Mol Brain Res 114(1):1–8
Tejada-Simon MV, Villasana LE, Serrano F, Klann E (2006) NMDA receptor activation induces translocation and activation of Rac in mouse hippocampal area CA1. Biochem Biophys Res Commun 343(2):504–512. doi:10.1016/j.bbrc.2006.02.183
Martinez LA, Tejada-Simon MV (2011) Pharmacological inactivation of the small GTPase Rac1 impairs long-term plasticity in the mouse hippocampus. Neuropharmacology 61(1–2):305–312. doi:10.1016/j.neuropharm.2011.04.017
O'Kane EM, Stone TW, Morris BJ (2004) Increased long-term potentiation in the CA1 region of rat hippocampus via modulation of GTPase signalling or inhibition of Rho kinase. Neuropharmacology 46(6):879–887. doi:10.1016/j.neuropharm.2003.11.020
Diana G, Valentini G, Travaglione S, Falzano L, Pieri M, Zona C, Meschini S, Fabbri A, Fiorentini C (2007) Enhancement of learning and memory after activation of cerebral Rho GTPases. Proc Natl Acad Sci U S A 104(2):636–641. doi:10.1073/pnas.0610059104
Martinez LA, Klann E, Tejada-Simon MV (2007) Translocation and activation of Rac in the hippocampus during associative contextual fear learning. Neurobiol Learn Mem 88(1):104–113. doi:10.1016/j.nlm.2007.01.008
Haditsch U, Leone DP, Farinelli M, Chrostek-Grashoff A, Brakebusch C, Mansuy IM, McConnell SK, Palmer TD (2009) A central role for the small GTPase Rac1 in hippocampal plasticity and spatial learning and memory. Mol Cell Neurosci 41(4):409–419. doi:10.1016/j.mcn.2009.04.005
Bamburg JR, Bloom GS (2009) Cytoskeletal pathologies of Alzheimer disease. Cell Motil Cytoskeleton 66(8):635–649. doi:10.1002/cm.20388
Allison DW, Gelfand VI, Spector I, Craig AM (1998) Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: differential attachment of NMDA versus AMPA receptors. J Neurosci 18(7):2423–2436
Maloney MT, Bamburg JR (2007) Cofilin-mediated neurodegeneration in Alzheimer's disease and other amyloidopathies. Mol Neurobiol 35(1):21–44
Davis RC, Marsden IT, Maloney MT, Minamide LS, Podlisny M, Selkoe DJ, Bamburg JR (2011) Amyloid beta dimers/trimers potently induce cofilin-actin rods that are inhibited by maintaining cofilin-phosphorylation. Mol Neurodegener 6:10. doi:10.1186/1750-1326-6-10 1750-1326-6-10
Davis RC, Maloney MT, Minamide LS, Flynn KC, Stonebraker MA, Bamburg JR (2009) Mapping cofilin-actin rods in stressed hippocampal slices and the role of cdc42 in amyloid-beta-induced rods. J Alzheimers Dis 18(1):35–50. doi:10.3233/JAD-2009-1122
Whiteman IT, Minamide LS, Gohde L, Bamburg JR, Goldsbury C (2011) Rapid changes in phospho-MAP/tau epitopes during neuronal stress: cofilin-actin rods primarily recruit microtubule binding domain epitopes. PLoS One 6(6):e20878. doi:10.1371/journal.pone.0020878
Maloney MT, Minamide LS, Kinley AW, Boyle JA, Bamburg JR (2005) Beta-secretase-cleaved amyloid precursor protein accumulates at actin inclusions induced in neurons by stress or amyloid beta: a feedforward mechanism for Alzheimer's disease. J Neurosci 25(49):11313–11321. doi:10.1523/JNEUROSCI.3711-05.2005
Zhu X, Raina AK, Boux H, Simmons ZL, Takeda A, Smith MA (2000) Activation of oncogenic pathways in degenerating neurons in Alzheimer disease. Int J Dev Neurosci 18(4–5):433–437
Perez SE, Getova DP, He B, Counts SE, Geula C, Desire L, Coutadeur S, Peillon H, Ginsberg SD, Mufson EJ (2012) Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease. Am J Pathol 180(2):526–540. doi:10.1016/j.ajpath.2011.10.027
Otth C, Mendoza-Naranjo A, Mujica L, Zambrano A, Concha II, Maccioni RB (2003) Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer's disease. NeuroReport 14(18):2403–2409. doi:10.1097/01.wnr.0000099988.54721.3c
Matsui C, Inoue E, Kakita A, Arita K, Deguchi-Tawarada M, Togawa A, Yamada A, Takai Y, Takahashi H (2012) Involvement of the gamma-secretase-mediated EphA4 signaling pathway in synaptic pathogenesis of Alzheimer's disease. Brain Pathol 22(6):776–787. doi:10.1111/j.1750-3639.2012.00587.x
Wang PL, Niidome T, Akaike A, Kihara T, Sugimoto H (2009) Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene. J Neurosci Res 87(9):2105–2114. doi:10.1002/jnr.22039
Santos Da Silva J, Schubert V, Dotti CG (2004) RhoA, Rac1, and cdc42 intracellular distribution shift during hippocampal neuron development. Mol Cell Neurosci 27(1):1–7. doi:10.1016/j.mcn.2004.03.008
Maillet M, Robert SJ, Cacquevel M, Gastineau M, Vivien D, Bertoglio J, Zugaza JL, Fischmeister R, Lezoualc'h F (2003) Crosstalk between Rap1 and Rac regulates secretion of sAPPalpha. Nat Cell Biol 5(7):633–639. doi:10.1038/ncb1007
Boo JH, Sohn JH, Kim JE, Song H, Mook-Jung I (2008) Rac1 changes the substrate specificity of gamma-secretase between amyloid precursor protein and Notch1. Biochem Biophys Res Commun 372(4):913–917. doi:10.1016/j.bbrc.2008.05.153
Mendoza-Naranjo A, Gonzalez-Billault C, Maccioni RB (2007) Abeta1-42 stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTPases. J Cell Sci 120(Pt 2):279–288. doi:10.1242/jcs.03323
Manterola L, Hernando-Rodriguez M, Ruiz A, Apraiz A, Arrizabalaga O, Vellon L, Alberdi E, Cavaliere F, Lacerda HM, Jimenez S, Parada LA, Matute C, Zugaza JL (2013) 1–42 beta-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death. Transl Psychiatr 3:e219. doi:10.1038/tp.2012.147
Petratos S, Li QX, George AJ, Hou X, Kerr ML, Unabia SE, Hatzinisiriou I, Maksel D, Aguilar MI, Small DH (2008) The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 131(Pt 1):90–108. doi:10.1093/brain/awm260
Kawarabayashi T, Shoji M, Younkin LH, Wen-Lang L, Dickson DW, Murakami T, Matsubara E, Abe K, Ashe KH, Younkin SG (2004) Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 24(15):3801–3809. doi:10.1523/JNEUROSCI.5543-03.2004
Benilova I, Karran E, De Strooper B (2012) The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci 15(3):349–357. doi:10.1038/nn.3028
Ma QL, Yang F, Calon F, Ubeda OJ, Hansen JE, Weisbart RH, Beech W, Frautschy SA, Cole GM (2008) p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis. J Biol Chem 283(20):14132–14143. doi:10.1074/jbc.M708034200
Zhao L, Ma QL, Calon F, Harris-White ME, Yang F, Lim GP, Morihara T, Ubeda OJ, Ambegaokar S, Hansen JE, Weisbart RH, Teter B, Frautschy SA, Cole GM (2006) Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat Neurosci 9(2):234–242. doi:10.1038/nn1630
Hayashi ML, Choi SY, Rao BS, Jung HY, Lee HK, Zhang D, Chattarji S, Kirkwood A, Tonegawa S (2004) Altered cortical synaptic morphology and impaired memory consolidation in forebrain- specific dominant-negative PAK transgenic mice. Neuron 42(5):773–787. doi:10.1016/j.neuron.2004.05.003
Yang K, Belrose J, Trepanier CH, Lei G, Jackson MF, MacDonald JF (2011) Fyn, a potential target for Alzheimer's disease. J Alzheimers Dis 27(2):243–252. doi:10.3233/JAD-2011-110353
Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E, Gotz J (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142(3):387–397. doi:10.1016/j.cell.2010.06.036
Um JW, Strittmatter SM (2013) Amyloid-beta induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease. Prion 7(1):37–41. doi:10.4161/pri.22212
Fujimura M, Usuki F (2012) Differing effects of toxicants (methylmercury, inorganic mercury, lead, amyloid beta, and rotenone) on cultured rat cerebrocortical neurons: differential expression of rho proteins associated with neurotoxicity. Toxicol Sci 126(2):506–514. doi:10.1093/toxsci/kfr352
Bate C, Williams A (2010) Amyloid-beta(1–40) inhibits amyloid-beta(1–42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration. J Alzheimers Dis 21(3):985–993. doi:10.3233/JAD-2010-100528
Shen JN, Wang DS, Wang R (2012) The protection of acetylcholinesterase inhibitor on beta-amyloid-induced the injury of neurite outgrowth via regulating axon guidance related genes expression in neuronal cells. Int J Clin Exp Pathol 5(9):900–913
Bernstein BW, Chen H, Boyle JA, Bamburg JR (2006) Formation of actin-ADF/cofilin rods transiently retards decline of mitochondrial potential and ATP in stressed neurons. Am J Physiol Cell Physiol 291(5):C828–C839. doi:10.1152/ajpcell.00066.2006
Huesa G, Baltrons MA, Gomez-Ramos P, Moran A, Garcia A, Hidalgo J, Frances S, Santpere G, Ferrer I, Galea E (2010) Altered distribution of RhoA in Alzheimer's disease and AbetaPP overexpressing mice. J Alzheimers Dis 19(1):37–56. doi:10.3233/JAD-2010-1203
Chacon PJ, Garcia-Mejias R, Rodriguez-Tebar A (2011) Inhibition of RhoA GTPase and the subsequent activation of PTP1B protects cultured hippocampal neurons against amyloid beta toxicity. Mol Neurodegener 6(1):14. doi:10.1186/1750-1326-6-14
Yu C, Nwabuisi-Heath E, Laxton K, Ladu MJ (2010) Endocytic pathways mediating oligomeric Abeta42 neurotoxicity. Mol Neurodegener 5:19. doi:10.1186/1750-1326-5-19
Zhou Y, Su Y, Li B, Liu F, Ryder JW, Wu X, Gonzalez-DeWhitt PA, Gelfanova V, Hale JE, May PC, Paul SM, Ni B (2003) Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science 302(5648):1215–1217. doi:10.1126/science.1090154
Desire L, Bourdin J, Loiseau N, Peillon H, Picard V, De Oliveira C, Bachelot F, Leblond B, Taverne T, Beausoleil E, Lacombe S, Drouin D, Schweighoffer F (2005) RAC1 inhibition targets amyloid precursor protein processing by gamma-secretase and decreases Abeta production in vitro and in vivo. J Biol Chem 280(45):37516–37525. doi:10.1074/jbc.M507913200
Kumanogoh H, Miyata S, Sokawa Y, Maekawa S (2001) Biochemical and morphological analysis on the localization of Rac1 in neurons. Neurosci Res 39(2):189–196
Abdul-Hay SO, Luo J, Ashghodom RT, Thatcher GR (2009) NO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade. J Neurochem 111(3):766–776. doi:10.1111/j.1471-4159.2009.06353.x
Eriksen JL, Sagi SA, Smith TE, Weggen S, Das P, McLendon DC, Ozols VV, Jessing KW, Zavitz KH, Koo EH, Golde TE (2003) NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J Clin Invest 112(3):440–449. doi:10.1172/JCI18162
Weggen S, Eriksen JL, Sagi SA, Pietrzik CU, Ozols V, Fauq A, Golde TE, Koo EH (2003) Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity. J Biol Chem 278(34):31831–31837. doi:10.1074/jbc.M303592200
Ding J, Li QY, Yu JZ, Wang X, Sun CH, Lu CZ, Xiao BG (2010) Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice. Mol Cell Neurosci 43(2):201–208. doi:10.1016/j.mcn.2009.11.001
Song Y, Chen X, Wang LY, Gao W, Zhu MJ (2013) Rho kinase inhibitor fasudil protects against beta-amyloid-induced hippocampal neurodegeneration in rats. CNS Neurosci Ther 19(8):603–610. doi:10.1111/cns.12116
Ostrowski SM, Wilkinson BL, Golde TE, Landreth G (2007) Statins reduce amyloid-beta production through inhibition of protein isoprenylation. J Biol Chem 282(37):26832–26844. doi:10.1074/jbc.M702640200
Pedrini S, Carter TL, Prendergast G, Petanceska S, Ehrlich ME, Gandy S (2005) Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK. PLoS Med 2(1):e18. doi:10.1371/journal.pmed.0020018
Mattson MP (2003) Gene-diet interactions in brain aging and neurodegenerative disorders. Ann Intern Med 139(5 Pt 2):441–444
Bonda DJ, Lee HG, Camins A, Pallas M, Casadesus G, Smith MA, Zhu X (2011) The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol 10(3):275–279. doi:10.1016/S1474-4422(11)70013-8
Smith J (2002) Human Sir2 and the ‘silencing’ of p53 activity. Trends Cell Biol 12(9):404–406
Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23(12):2369–2380. doi:10.1038/sj.emboj.7600244
Antebi A (2004) Tipping the balance toward longevity. Dev Cell 6(3):315–316
Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, Puigserver P, Sadoshima J, Deng H, Pedrini S, Gandy S, Sauve AA, Pasinetti GM (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281(31):21745–21754. doi:10.1074/jbc.M602909200
Tang BL (2005) Alzheimer's disease: channeling APP to non-amyloidogenic processing. Biochem Biophys Res Commun 331(2):375–378. doi:10.1016/j.bbrc.2005.03.074
Qin W, Chachich M, Lane M, Roth G, Bryant M, de Cabo R, Ottinger MA, Mattison J, Ingram D, Gandy S, Pasinetti GM (2006) Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus). J Alzheimers Dis 10(4):417–422
Feng X, Liang N, Zhu D, Gao Q, Peng L, Dong H, Yue Q, Liu H, Bao L, Zhang J, Hao J, Gao Y, Yu X, Sun J (2013) Resveratrol inhibits beta-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathway. PLoS One 8(3):e59888. doi:10.1371/journal.pone.0059888
Linseman DA, Laessig T, Meintzer MK, McClure M, Barth H, Aktories K, Heidenreich KA (2001) An essential role for Rac/Cdc42 GTPases in cerebellar granule neuron survival. J Biol Chem 276(42):39123–39131. doi:10.1074/jbc.M103959200 M103959200
Le SS, Loucks FA, Udo H, Richardson-Burns S, Phelps RA, Bouchard RJ, Barth H, Aktories K, Tyler KL, Kandel ER, Heidenreich KA, Linseman DA (2005) Inhibition of Rac GTPase triggers a c-Jun- and Bim-dependent mitochondrial apoptotic cascade in cerebellar granule neurons. J Neurochem 94(4):1025–1039. doi:10.1111/j.1471-4159.2005.03252.x
Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA (2010) Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 59(4–5):290–294. doi:10.1016/j.neuropharm.2010.04.005
Choi DH, Cristovao AC, Guhathakurta S, Lee J, Joh TH, Beal MF, Kim YS (2012) NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease. Antioxid Redox Signal 16(10):1033–1045. doi:10.1089/ars.2011.3960
Hashimoto Y, Chiba T, Yamada M, Nawa M, Kanekura K, Suzuki H, Terashita K, Aiso S, Nishimoto I, Matsuoka M (2005) Transforming growth factor beta2 is a neuronal death-inducing ligand for amyloid-beta precursor protein. Mol Cell Biol 25(21):9304–9317. doi:10.1128/MCB.25.21.9304-9317.2005
Tachi N, Hashimoto Y, Matsuoka M (2012) MOCA is an integrator of the neuronal death signals that are activated by familial Alzheimer's disease-related mutants of amyloid beta precursor protein and presenilins. Biochem J 442(2):413–422. doi:10.1042/BJ20100993
Musilli M, Nicolia V, Borrelli S, Scarpa S, Diana G (2013) Behavioral effects of Rho GTPase modulation in a model of Alzheimer's disease. Behav Brain Res 237:223–229. doi:10.1016/j.bbr.2012.09.043
Loizzo S, Rimondini R, Travaglione S, Fabbri A, Guidotti M, Ferri A, Campana G, Fiorentini C (2013) CNF1 increases brain energy level, counteracts neuroinflammatory markers and rescues cognitive deficits in a murine model of Alzheimer's disease. PLoS One 8(5):e65898. doi:10.1371/journal.pone.0065898
Borrelli S, Musilli M, Martino A, Diana G (2013) Long-lasting efficacy of the cognitive enhancer cytotoxic necrotizing factor 1. Neuropharmacology 64(1):74–80. doi:10.1016/j.neuropharm.2012.05.031
De Viti S, Martino A, Musilli M, Fiorentini C, Diana G (2010) The Rho GTPase activating CNF1 improves associative working memory for object-in-place. Behav Brain Res 212(1):78–83. doi:10.1016/j.bbr.2010.03.049
De Filippis B, Fabbri A, Simone D, Canese R, Ricceri L, Malchiodi-Albedi F, Laviola G, Fiorentini C (2012) Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome. Neuropsychopharmacology 37(5):1152–1163. doi:10.1038/npp.2011.301
Haag MD, Hofman A, Koudstaal PJ, Stricker BH, Breteler MM (2009) Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam study. J Neurol Neurosurg Psychiatr 80(1):13–17. doi:10.1136/jnnp.2008.150433
Samuel F, Hynds DL (2010) RHO GTPase signaling for axon extension: is prenylation important? Mol Neurobiol 42(2):133–142. doi:10.1007/s12035-010-8144-2
Hamano T, Yen SH, Gendron T, Ko LW, Kuriyama M (2012) Pitavastatin decreases tau levels via the inactivation of Rho/ROCK. Neurobiol Aging 33(10):2306–2320. doi:10.1016/j.neurobiolaging.2011.10.020
Yang P, Arnold SA, Habas A, Hetman M, Hagg T (2008) Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice. J Neurosci 28(9):2231–2241. doi:10.1523/JNEUROSCI.3574-07.2008 28/9/2231
Hitoshi S, Seaberg RM, Koscik C, Alexson T, Kusunoki S, Kanazawa I, Tsuji S, van der Kooy D (2004) Primitive neural stem cells from the mammalian epiblast differentiate to definitive neural stem cells under the control of Notch signaling. Genes Dev 18(15):1806–1811. doi:10.1101/gad.1208404 18/15/1806
Bolognin S, Blanchard J, Wang X, Basurto-Islas G, Tung YC, Kohlbrenner E, Grundke-Iqbal I, Iqbal K (2012) An experimental rat model of sporadic Alzheimer's disease and rescue of cognitive impairment with a neurotrophic peptide. Acta Neuropathol 123(1):133–151. doi:10.1007/s00401-011-0908-x
Pertz O (2010) Spatio-temporal Rho GTPase signaling — where are we now? J Cell Sci 123(Pt 11):1841–1850. doi:10.1242/jcs.064345 123/11/1841
Harvey CD, Yasuda R, Zhong H, Svoboda K (2008) The spread of Ras activity triggered by activation of a single dendritic spine. Science 321(5885):136–140. doi:10.1126/science.1159675 1159675
Yasuda R, Murakoshi H (2011) The mechanisms underlying the spatial spreading of signaling activity. Curr Opin Neurobiol 21(2):313–321. doi:10.1016/j.conb.2011.02.008
Yoshizaki H, Ohba Y, Kurokawa K, Itoh RE, Nakamura T, Mochizuki N, Nagashima K, Matsuda M (2003) Activity of Rho-family GTPases during cell division as visualized with FRET-based probes. J Cell Biol 162(2):223–232. doi:10.1083/jcb.200212049 jcb.200212049
Yoshizaki H, Aoki K, Nakamura T, Matsuda M (2006) Regulation of RalA GTPase by phosphatidylinositol 3-kinase as visualized by FRET probes. Biochem Soc Trans 34(Pt 5):851–854. doi:10.1042/BST0340851
Cherfils J, Zeghouf M (2013) Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol Rev 93(1):269–309. doi:10.1152/physrev.00003.2012 93/1/269
Lamarche N, Tapon N, Stowers L, Burbelo PD, Aspenstrom P, Bridges T, Chant J, Hall A (1996) Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade. Cell 87(3):519–529
Lorenzetto E, Ettorre M, Pontelli V, Bolomini-Vittori M, Bolognin S, Zorzan S, Laudanna C, Buffelli M (2013) Rac1 selective activation improves retina ganglion cell survival and regeneration. PLoS One 8(5):e64350. doi:10.1371/journal.pone.0064350
Acknowledgments
This work was supported by funding of the University of Verona, “Fondazione Cariverona” project Verona Nanomedicine Initiative.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bolognin, S., Lorenzetto, E., Diana, G. et al. The Potential Role of Rho GTPases in Alzheimer's Disease Pathogenesis. Mol Neurobiol 50, 406–422 (2014). https://doi.org/10.1007/s12035-014-8637-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-014-8637-5